Radicle Science highlights findings from large CBD study

Radicle Science recently released its findings from the Radicle ACES (Advancing CBD Education and Science) study to determine the effectiveness of CBD products. The open label trial examined over a dozen US brands to determine whether botanical products containing CBD deliver therapeutic benefits across five health outcomes, including well-being, quality of life, longer-term pain, feelings of anxiety, and sleep quality.

Jeff Chen, MD, Co-founder and CEO of Radicle Science, told NutraIngredients-USA​ that the goal is to generate real world evidence indicative of the behavior and health outcomes of the tens of millions of Americans who use CBD regularly.  

“Official clinical research on these CBD products is lacking due to decades of research restrictions and unclear regulations that continue to this day. The Radicle ACES study was a 4-week 14-arm open label randomized trial that involved nearly 3,000 participants, 13 products, and a waitlist control group. It is history’s largest randomized controlled trial ever done on CBD and was completed at the end of 2021.” ​

The brands that participated in the Radicle ACES study include: ALTWELL, Columbia Care, Healer, Lord Jones, Maven Hemp, MD FARMA, Peels (a citrus-derived brand), Prospect Farms, PURAURA Naturals from Enhanced Botanicals, Rae Wellness, Trokie, and Verséa Wellness.  

“We sought intentional diversity in the attributes of these 13 products to reflect the thousands of different CBD products available in the US, and thus these products varied in formulation, dose, and form factor,”​ Chen added.   

Be the first to comment

Leave a Reply

Your email address will not be published.


*